Please login to the form below

Medical Advisor: A new role is created at Porterhouse Medical

Porterhouse Medical Group is delighted to announce that Dr. Beth Wynne-Evans will be taking on the role of Medical Advisor.

This is a new role within Porterhouse, created to maximise the value that Beth’s medical expertise can add to our clients’ projects. The role will encompass both medical writing and business development activities, plus Beth will be working closely with our directors to add clinical insights to our proposals and programmes, across all accounts.

This is a great example of an individual using Porterhouse’s Career Development Panel to identify and develop a non-traditional path that maximises their skills and experiences to improve the customer experience.

Congratulations to Beth in her new role. The team at Porterhouse Medical wish her every success.

If you would like information on career development at Porterhouse and our outstanding scientific services please visit: www.porterhousemedical.com. To find out how we can work with you as a valued strategic partner, please get in touch: Mark.Walker@porterhousemedical.com.

26th November 2018

Share

Tags

Company Details

Porterhouse Medical Group

+44 (0)118 913 9100

Contact Website

Address:
4 Windsor Square
Silver Street
Reading
RG1 2TH
United Kingdom

Latest content on this profile

Porterhouse celebrates 12 months of smarter insight-driven medical communications
Strategic scientific and medical communications agency, Porterhouse Medical Group, is celebrating the first birthday of Porterhouse Insights, its global research, insight and evidence consultancy.
Porterhouse Medical Group
World AIDS Day 2018: Fighting the stigma surrounding HIV
To support World AIDS Day 2018 and to help tackle the stigma surrounding the condition, Porterhouse Medical explores the misconceptions surrounding HIV/AIDS.
Porterhouse Medical Group
Medical Advisor: A new role is created at Porterhouse Medical

Porterhouse Medical Group
Porterhouse Medical is raising awareness for pancreatic cancer, here’s why…

Porterhouse Medical Group
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically underfunded and awareness is low, in part because of widespread misconceptions regarding the disease. This World Pancreatic Cancer Day, let’s educate ourselves so that we can all ‘Demand Better’ in the fight against the world’s toughest cancer.
Porterhouse Medical Group
Porterhouse enhances its client services and creative teams with a double recruitment

Porterhouse Medical Group